NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ceretype Neuromedicine, Inc.

Ceretype Neuromedicine, Inc.

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://ceretype.com/

Last Round

Seed

Jan 4, 2024

Total Funding Raised

$3.67M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ceretype Neuromedicine, Inc. is a biotechnology company that provides a functional MRI (fMRI) platform to analyze brain circuitry and develop biomarkers for psychiatric and neurological drug development.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Imaging, Healthcare Analytics, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

functional MRIfMRIneuroimagingprecision psychiatrybiomarker platformCNS drug developmentclinical trial imagingpatient stratificationbrain circuitry mappingdigital biomarkersmedical AIhealthcare analyticsneurotechclinical trial softwareAI in pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ceretype Neuromedicine, Inc. Comparables

Compare Ceretype Neuromedicine, Inc. with similar companies based on industry and business-model similarity.

Ceretype Neuromedicine, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ADM Diagnostics, Inc.
81%
IXICO plc
78%
Darmiyan
74%

Ceretype Neuromedicine, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 4, 2024
AcceleratorMar 2, 2023
SeedNov 8, 2021

Key People

Founding team and executive leadership

Emily Stern

CEO, Co-Founder

Founding Team

Ceretype Neuromedicine, Inc. Investors

Notable investors and investment history

Ceretype Neuromedicine, Inc. investors
InvestorRounds
Catalytic Impact FoundationSeed
One Mind AcceleratorSeed, Accelerator
Leafy TunnelSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 174% MoM.

  • Jan 2, 2026

    Monthly visitors increased 83% MoM.

Ceretype Neuromedicine, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ceretype Neuromedicine, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ceretype Neuromedicine, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range5
Year Founded2020
Last FundingJan 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.